drugset / Trial / NCT03218241
Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote
RandomizedSingle-groupDouble-blindOther
Summary
This is a single center, double-blind, randomized, placebo-controlled, ascending, single dose study of PRT064445 or its matching placebo, in healthy subjects.
Timeline
- Start
- 2012-06
- Primary completion
- 2012-09
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Andexanet alfa | Protein / enzyme biologic | — | Intravenous |
Indications
No indication recorded.